Review Article
Mesenchymal Stem Cells in Renal Fibrosis: The Flame of Cytotherapy
Table 1
Literature summary of BM-MSC in the antifibrotic process.
| Researcher | Fibrogenic signal pathway involved | Delivery method | Animal model | Heterogeneity |
| da Silva et al. [51] | Not mentioned | Abdominal vena cava | Rat UUO | Syngeneic | Asanuma et al. [52] | Not mentioned | Renal artery | Rat UUO | Xenogeneic (from human) | Wu et al. [53] | P38 and NF-κB | i.v. | Mouse BSA-induced proteinuria (CKD model) | Murine | Ninichuk et al. [55] | Not mentioned | Tail vein | COL4A3-deficient mouse (Alport disease model) | Murine | Lang and Dai [56] | TGF-β1/Smad3 | i.p. | Rat STZ-induced diabetic nephropathy | Syngeneic | Matsui et al. [57] | JAK-STAT3 | Renal artery | Rat UUO | Xenogeneic (from human) | Song et al. [45] | NF-κB and ERK | Tail vein | ADR-induced nephropathy mouse model | Xenogeneic (from human) | Wang et al. [61] | TGF-β1 | i.v. | Mouse UUO | Xenogeneic (from human) |
|
|
i.v.: intravenously; i.p.: intraperitoneally.
|